MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
IMNM - Immunome Inc
$38.27
-4.97(-11.49%)8:59:56 PM 2/25/2021
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • MACD is crossing MACD signal line at 1.4. MACD crossing signal line is bullish signal.
Stock Statistics
MarketCap454.4M
PE Ratio
PEG Ratio
P/B
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %1%
Held by Institutions %11%
1 Day Vol Adjusted Return-0.5
1 Month Vol Adjusted Return6.4
3 Month Vol Adjusted Return19.0
6 Month Vol Adjusted Return
20 Days SMA Price ZScore1.6
50 Days SMA Price ZScore2.5
12 -26 Days PPO23.2
1 Month Average Short Volume Ratio44.2
1 Day Volume Change ZScore-0.2
1 Month Daily Vol21.6
Related Topics
leak data

Related Topics

Stock news